Brain metastases: pathobiology and emerging targeted therapies

Matthias Preusser; David Capper; Aysegül Ilhan-Mutlu; Anna Sophie Berghoff; Peter Birner; Rupert Bartsch; Christine Marosi; Christoph Zielinski; Minesh P. Mehta; Frank Winkler; Wolfgang Wick; Andreas von Deimling

doi:10.1007/s00401-011-0933-9

Brain metastases: pathobiology and emerging targeted therapies

Matthias Preusser, David Capper, Aysegül Ilhan-Mutlu, Anna Sophie Berghoff, Peter Birner, Rupert Bartsch, Christine Marosi, Christoph Zielinski, Minesh P. Mehta, Frank Winkler, Wolfgang Wick, Andreas von Deimling

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Acta Neuropathologica
Volume	123
DOIs	https://doi.org/10.1007/s00401-011-0933-9
State	Published - Feb 1 2012

Disciplines

Biology
Pathology
Immunology and Infectious Disease

Access to Document

10.1007/s00401-011-0933-9License: Unspecified

Cite this

@article{cf13ce5b6b3643ffb7c9cc7463cad8b6,

title = "Brain metastases: pathobiology and emerging targeted therapies",

author = "Matthias Preusser and David Capper and Ayseg{\"u}l Ilhan-Mutlu and Berghoff, \{Anna Sophie\} and Peter Birner and Rupert Bartsch and Christine Marosi and Christoph Zielinski and Mehta, \{Minesh P.\} and Frank Winkler and Wolfgang Wick and \{von Deimling\}, Andreas",

note = "Brain metastases (BM) are common in cancer patients and are associated with high morbidity and poor prognosis, even after intensive multimodal therapy including resection, radiotherapy (stereotactic radiosurgery or whole brain radiotherapy) and chemotherapy. However, advances in the understanding of the pathobiology of BM and the development of molecular targeted agents hold promise for improved prophylaxis and therapy of BM.",

year = "2012",

month = feb,

day = "1",

doi = "10.1007/s00401-011-0933-9",

language = "American English",

volume = "123",

journal = "Acta Neuropathologica",

}

TY - JOUR

T1 - Brain metastases: pathobiology and emerging targeted therapies

AU - Preusser, Matthias

AU - Capper, David

AU - Ilhan-Mutlu, Aysegül

AU - Berghoff, Anna Sophie

AU - Birner, Peter

AU - Bartsch, Rupert

AU - Marosi, Christine

AU - Zielinski, Christoph

AU - Mehta, Minesh P.

AU - Winkler, Frank

AU - Wick, Wolfgang

AU - von Deimling, Andreas

N1 - Brain metastases (BM) are common in cancer patients and are associated with high morbidity and poor prognosis, even after intensive multimodal therapy including resection, radiotherapy (stereotactic radiosurgery or whole brain radiotherapy) and chemotherapy. However, advances in the understanding of the pathobiology of BM and the development of molecular targeted agents hold promise for improved prophylaxis and therapy of BM.

PY - 2012/2/1

Y1 - 2012/2/1

UR - https://link.springer.com/content/pdf/10.1007%2Fs00401-011-0933-9.pdf

U2 - 10.1007/s00401-011-0933-9

DO - 10.1007/s00401-011-0933-9

M3 - Article

VL - 123

JO - Acta Neuropathologica

JF - Acta Neuropathologica

ER -

Brain metastases: pathobiology and emerging targeted therapies

Disciplines

Access to Document

Other files and links

Cite this